FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Vet Ophthalmol / α2-Macroglobulin Concentrations in Canine and Equine S...
Veterinary ophthalmology2025; doi: 10.1111/vop.70057

α2-Macroglobulin Concentrations in Canine and Equine Serum Donors.

Abstract: To determine if serum α2-macroglobulin (A2M) concentration varies based on donor species-canine or equine-and signalment. Methods: Serum A2M concentration ([A2M]) was measured in healthy dogs (n = 30) and horses (n = 31) using species-specific ELISAs. Results: Canine and equine [A2M] median (IQR; range) were 98.70 ng/mL (92.79 ng/mL; 34.33-696.18 ng/mL) and 557 000 ng/mL (437 900 ng/mL; 62 600-3 042 900 ng/mL), respectively. Equine [A2M] was significantly higher than canine [A2M]. Depending on the statistical analysis performed, sex had either no statistical (p = 0.17) or medium practical (η = 0.07) effect on canine serum [A2M], with male dogs having higher [A2M] practically. There was no association between serum [A2M] and duration of serum storage at -80°C. Conclusions: Equine serum [A2M] was exponentially higher than that of dogs. Sex may affect [A2M] in dogs. Further study is needed to evaluate how this difference affects antiprotease activity.
© 2025 American College of Veterinary Ophthalmologists.
Get Full Text
Publication Date: 2025-08-04 PubMed ID: 40755436DOI: 10.1111/vop.70057Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the variation in serum α2-macroglobulin (A2M) concentration in dogs and horses and how factors such as gender and serum storage duration affect it.

Research Purpose and Methods

  • The research focused on determining if the serum α2-macroglobulin (A2M) — a significant proteinase inhibitor and regulatory element in some enzymatic processes — varies across two different donor species, dogs (canine) and horses (equine). It also sought to uncover whether ‘signalment’ (the characteristics of the animal such as age, breed, or sex) and storage duration impacted these concentrations.
  • The researchers employed a species-specific Enzyme-Linked Immunosorbent Assay (ELISA), a common laboratory technique used for measuring specific protein concentrations in a sample, like serum in this case. This was done on samples from 30 healthy dogs and 31 healthy horses.

Research Results

  • Through analyzing the A2M concentrations, researchers found the median value to be significantly different across the two species. In dogs, the A2M concentration was 98.70 ng/mL while in horses, it was exponentially higher at 557,000 ng/mL. Thus, the equine serum A2M concentration was significantly higher than the canine one.
  • Depending on the statistical analysis, researchers found that sex may have varying levels of impact on canine serum A2M concentrations, with male dogs generally having a higher concentration.
  • The duration of serum storage at a temperature of -80°C showed no significant association with the A2M concentration. Hence, the study could not establish this variable as a factor influencing A2M concentration.

Conclusion and Future Directions

  • Based on their findings, researchers concluded that the serum A2M concentration was species-specific and varied significantly between dogs and horses, with the latter having a much higher concentration.
  • Sex, particularly in dogs, might potentially influence A2M concentrations — though further research is necessary to substantiate this impact.
  • Given the important role A2M plays in inhibiting proteinase activities and possibly other enzymatic processes, the study emphasizes the need for a deeper understanding of how these inter-species variations and potentially sex-specific variations affect antiprotease activity.

Cite This Article

APA
Zimmerman KL, Diehl KA. (2025). α2-Macroglobulin Concentrations in Canine and Equine Serum Donors. Vet Ophthalmol. https://doi.org/10.1111/vop.70057

Publication

Veterinary ophthalmology
ISSN: 1463-5224
NlmUniqueID: 100887377
Country: England
Language: English

Researcher Affiliations

Zimmerman, Kelli L
  • Animal Eye Associates of St. Louis, St. Louis, Missouri, USA.
Diehl, Kathryn A
  • Department of Small Animal Medicine & Surgery, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.

Grant Funding

  • University of Georgia Small Animal Medicine internal research grant

References

This article includes 32 references
  1. Ledbetter EC, Gilger BC. Diseases and Surgery of the Canine Cornea and Sclera. Veterinary Ophthalmology (Wiley‐Blackwell, 2013), 979–980.
  2. Guyonnet A, Desquilbet L, Faure J, Bourguet A, Donzel E, Chahory S. Outcome of Medical Therapy for Keratomalacia in Dogs. Journal of Small Animal Practice 61, no. 4 (2020): 253–258.
  3. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial Effect of Artificial Tears Made With Autologous Serum in Patients With Keratoconjunctivitis Sicca. Arthritis and Rheumatism 27, no. 4 (1984): 459–461.
  4. Kono I, Kono K, Narushima K. Beneficial Effect of the Local Application of Plasma Fibronectin and Autologous Serum in Patients With the Keratoconjunctivitis Sicca of Sjögren's Syndrome. Ryūmachi 26, no. 5 (1986): 339–343.
  5. Tsubota K, Goto E, Fujita H. Treatment of Dry Eye by Autologous Serum Application in Sjögren's Syndrome. British Journal of Ophthalmology 83 (1999): 390–395.
  6. Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of Superior Limbic Keratoconjunctivitis by Application of Autologous Serum. Cornea 20 (2001): 807–810.
  7. del Castillo JM, de la Casa JM, Sardiña RC. Treatment of Recurrent Corneal Erosions Using Autologous Serum. Cornea 21 (2002): 781–783.
  8. Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT. Autologous Serum Eyedrops for Dry Eyes and Epithelial Defects: Clinical and In Vitro Toxicity Studies. British Journal of Ophthalmology 85, no. 10 (2001): 1188–1197.
  9. Rocha EM, Pelegrino FS, de Paiva CS, Vigorito AC, de Souza CA. GVHD Dry Eyes Treated With Autologous Serum Tears. Bone Marrow Transplantation 25 (2000): 1101–1103.
  10. Ogawa Y, Okamoto S, Mori T. Autologous Serum Eye Drops for the Treatment of Severe Dry Eye in Patients With Chronic Graft‐Versus‐Host Disease. Bone Marrow Transplantation 31 (2003): 579–583.
  11. Tsubota K, Satake Y, Ohyama M. Surgical Reconstruction of the Ocular Surface in Advanced Ocular Cicatricial Pemphigoid and Stevens‐Johnson Syndrome. American Journal of Ophthalmology 122 (1996): 38–52.
  12. Tsubota K, Shimazaki J. Surgical Treatment of Children Blinded by Stevens‐Johnson Syndrome. American Journal of Ophthalmology 128 (1999): 573–581.
  13. Conway ED, Stiles J, Townsend WM. Evaluation of Species Differences and the Effects of Storage Duration and Temperature on the Anticollagenase Efficacy of Canine, Feline, and Equine Serum. American Journal of Veterinary Research 76 (2015): 989–995.
  14. Conway ED, Stiles JS, Townsend WM, Weng HY. Comparison of the In Vitro Anticollagenase Efficacy of Homologous Serum and Plasma on Degradation of Corneas of Cats, Dogs, and Horses. American Journal of Veterinary Research 77, no. 6 (2016): 627–633.
  15. Kimmitt BA, Moore GE, Stiles J. Comparison of the Efficacy of Various Concentrations and Combinations of Serum, Ethylenediaminetetraacetic Acid, Tetracycline, Doxycycline, Minocycline, and N‐Acetylcysteine for Inhibition of Collagenase Activity in an In Vitro Corneal Degradation Model. American Journal of Veterinary Research 79, no. 5 (2018): 555–561.
  16. Barrett AJ, Starkey PM. The Interaction of α2‐Macroglobulin With Proteinases: Characteristics and Specificity of the Reaction, and a Hypothesis Concerning Its Molecular Mechanism. Biochemical Journal 133 (1973): 709–724.
  17. Berman MB, Barber JC, Talamo RC, Langley CE. Corneal Ulceration and the Serum Antiproteases. Investigative Ophthalmology & Visual Science 12, no. 10 (1973): 759–770.
  18. Berman M, Gordon J, Garcia LA, Gage J. Corneal Ulceration and the Serum Antiproteases. II: Complexes of Corneal Collagenases and Alpha Macroglobulins. Experimental Eye Research 20 (1975): 231–244.
  19. Berman MB. Collagenase Inhibitors: Rationale for Their Use in Treating Corneal Ulceration. International Ophthalmology Clinics 15 (1975): 49–66.
  20. Wooley DE, Roberts DR, Evanson JM. Small Molecular Weight Beta 1 Serum Protein Which Specifically Inhibits Human Collagenases. Nature 261 (1976): 325–327.
  21. Hibbetts K, Hines B, Williams D. An Overview of Proteinase Inhibitors. Journal of Veterinary Internal Medicine 13 (1999): 302–308.
  22. James K, Johnson G, Fudenberg HH. The Quantitative Estimation of α2‐Macroglobulin in Normal, Pathological and Cord Sera. Clinica Chimica Acta 14, no. 2 (1966): 207–214.
  23. James K, Merriman J, Gray RS, Duncan LJP, Herd R. Serum α2‐Macroglobulin Levels in Diabetes. Journal of Clinical Pathology 33 (1980): 163–166.
  24. Yang S, Chen L, Sun S. Glycoproteins Identified From Heart Failure and Treatment Models. Proteomics 15 (2015): 567–579.
  25. Ganrot PO, Gydell K, Ekelund H. Serum Concentration of Alpha‐2‐Macroglobulin, Haptoglobulin and Alpha‐1‐Antitrypsin in Diabetes Mellitus. Acta Endocrinologica 55, no. 3 (1967): 537–544.
  26. Ganrot PO. Variation of the α2‐Macroglobulin Homologue With Age in Some Animals. Scandinavian Journal of Clinical and Laboratory Investigation 21 (1968): 177–181.
  27. Ruaux CG, Atwell RB. Levels of Total α‐Macroglobulin and Trypsin‐Like Immunoreactivity Are Poor Indicators of Clinical Severity in Spontaneous Canine Acute Pancreatitis. Research in Veterinary Science 67 (1999): 83–87.
  28. Abate O, Zanatta R, Malisano T, Dotta U. Canine Serum Protein Patterns Using High Resolution Electrophoresis (HRE). Veterinary Journal 159 (2000): 154–160.
  29. Matthews AG. Serum Protein Electrophoresis in Horses and Ponies. Equine Veterinary Journal 14, no. 4 (1982): 322–324.
  30. Wilding P, Adham NF, Mehl JW, Haverback BJ. Alpha‐2‐Macroglobulin Concentrations in Human Serum. Nature 214 (1967): 1226–1227.
  31. Sullivan GM, Feinn R. Using Effect Size—Or Why the P Value Is Not Enough. Journal of Graduate Medical Education 4, no. 3 (2012): 279–282.
    doi: 10.4300/jgme-d-12-00156.1google scholar: lookup
  32. Cano-Corres R, Sánches-Álvarez J, Fuentes-Arderiu X. The Effect Size: Beyond Statistical Significance. Electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine 23, no. 1 (2012): 19–23.

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,383 horse owners like you who receive our email updates on horse health and nutrition.